FDA正式批准瑞德西韦用于新冠肺炎治疗,此前WHO否认了它的疗效

2020-10-23 网络 网络

2020年10月22日,FDA正式批准瑞德西韦上市,商品名为Veklury。但是,WHO的大团结试验,仅仅发现瑞德西韦只有轻微的作用。现在FDA批准了,你是支持用还是不支持用?

2020年10月22日,FDA正式批准瑞德西韦上市,商品名为Veklury。但是,WHO的大团结试验,仅仅发现瑞德西韦只有轻微的作用。现在FDA批准了,你是支持用还是不支持用?

瑞德西韦获批适应症为12岁以上新冠肺炎住院患者的治疗。

瑞德西韦为冻干粉制剂,每支100mg,稀释和使用方法如下。

瑞德西韦为核苷类RNA依赖的RNA聚合酶(RdRp)竞争性抑制剂。

2020年10月8日,新英格兰医学期刊(NEJM)发表了关于瑞德西韦治疗新冠肺炎的文章。
瑞德西韦的临床共入组1062例新冠肺炎住院患者,瑞德西韦治疗组541例,安慰剂组521例。平均痊愈时间,瑞德西韦为10天,安慰剂组为15天。生存曲线方面,瑞德西韦组15天死亡率为6.7%,安慰剂组为11.9%。瑞德西韦29天死亡率为11.4%,安慰剂组为15.2%。

总结

瑞德西韦成为FDA完全批准的首个新冠肺炎治疗药物,吉利德股价盘后上涨5%。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=899788, encodeId=7e42899e8831, content=那么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2105290670, createdName=14861c21m75暂无昵称, createdTime=Tue Nov 17 09:34:20 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028685, encodeId=6d65102868566, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032691, encodeId=e0661032691ac, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893948, encodeId=2717893948ab, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>期待疗效, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Fri Oct 23 14:18:20 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-11-17 14861c21m75暂无昵称

    那么厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=899788, encodeId=7e42899e8831, content=那么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2105290670, createdName=14861c21m75暂无昵称, createdTime=Tue Nov 17 09:34:20 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028685, encodeId=6d65102868566, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032691, encodeId=e0661032691ac, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893948, encodeId=2717893948ab, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>期待疗效, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Fri Oct 23 14:18:20 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=899788, encodeId=7e42899e8831, content=那么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2105290670, createdName=14861c21m75暂无昵称, createdTime=Tue Nov 17 09:34:20 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028685, encodeId=6d65102868566, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032691, encodeId=e0661032691ac, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893948, encodeId=2717893948ab, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>期待疗效, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Fri Oct 23 14:18:20 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 内科新手

    谢谢梅斯提供这么好的信息,学到很多

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=899788, encodeId=7e42899e8831, content=那么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2105290670, createdName=14861c21m75暂无昵称, createdTime=Tue Nov 17 09:34:20 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028685, encodeId=6d65102868566, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1032691, encodeId=e0661032691ac, content=谢谢梅斯提供这么好的信息,学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=内科新手, createdTime=Fri Oct 23 15:44:37 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893948, encodeId=2717893948ab, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>期待疗效, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201022/70e28c5f379546819d312bcac8ecc124/f1b01dcf10fc46728cc0eff8ad54139b.jpg, createdBy=d92f5428273, createdName=一颗酸酸的小李子, createdTime=Fri Oct 23 14:18:20 CST 2020, time=2020-10-23, status=1, ipAttribution=)]

相关资讯

10月22日全球新冠肺炎(COVID-19)疫情简报,确诊超4142万,疫情进入快速增长趋势

据Worldometers实时统计数据显示,截至北京时间10月22日07时01分,全球新冠肺炎(COVID-19)确诊病例达4142万例,新增399,838例至41,424,568例,死亡病例达113

Science :重磅!新冠病毒为何具有高度传染性?科学家找到了它们的“弱点”

自从青岛冷链食品外包装上分离到新冠活病毒后,我国新冠疫情防控重点已从“防人”转向“人物并防”。尽早找到SARS-CoV-2病毒的弱点,,研制相应疫苗与药物是目前唯一的解决办法。

NEJM:Tocilizumab用于新冠肺炎住院患者的治疗

Tocilizumab治疗不能降低新冠肺炎患者插管或死亡风险

PNAS:细胞膜纳米囊泡,缓解新冠肺炎的新疗法

由新冠病毒SARS-CoV-2引起的COVID-19新冠肺炎大流行,给人类的医疗、经济、生活带来了巨大的负面影响。如何快速应对正在发生的COVID-19新冠肺炎以及潜在的新发流行疾病?

10月23日全球新冠肺炎(COVID-19)疫情简报,确诊超4197万,第二年疫情远超第一年,与1918年大流感类似

Worldometers世界实时统计数据显示,截至北京时间10月23日9时49分,全球新冠肺炎(COVID-19)累计确诊病例超过4197万例,达到41,974,001例,日新增再创记录,超过47万,

JAMA速递| 2020年新冠大流行美国高死亡率的多篇点评

JAMA发表的两篇最新报道提供了美国与新冠病毒(COVID-19)大流行相关的死亡率的最新估计。